What is Enlaza Geb's official website?

Enlaza Geb's website is https://www.enlaza.red/

What is Enlaza Geb's industry?

Enlaza Geb's industry is Electric Power Transmission, Control, and Distribution

Who are Enlaza Geb's top competitors?

Enlaza Geb's top competitors are , , , , , ,

Enlaza Geb company information, Employees & Contact Information

Explore related pages

Enlaza Geb email format Enlaza Geb management contacts

Related company profiles:

Empresa líder dedicada a la transmisión de energía eléctrica en Colombia

Employees: 138
Founded: -
Address: Bogotá, Co
Industry: Electric Power Transmission, Control, And Distribution
NAICS: Electric Power Transmission, Control, and Distribution

Electric Bulk Power Transmission and Control

Electric Power Distribution
Website: https://www.enlaza.red/
HQ: Bogotá
Competitors: Grupo Energía de Bogotá, Transportadora de Gas Internacional S.A., ISA INTERCOLOMBIA, JE Jaimes Ingenieros S.A., ConectaGt, ISA Interconexión Eléctrica S.A. E.S.P., Ecopetrol, Cenit Transporte y Logística de Hidrocarburos, Celsia Energía, Enel Colombia.

Enlaza Geb Questions

News

Editor’s pick: Enlaza Therapeutics - Nature

Editor’s pick: Enlaza Therapeutics Nature

Firm Advises Enlaza on IP Matters Related to Multi-Target Drug Discovery Collaboration with Vertex Pharmaceuticals - Wilson Sonsini

Firm Advises Enlaza on IP Matters Related to Multi-Target Drug Discovery Collaboration with Vertex Pharmaceuticals Wilson Sonsini

Vertex locks on to $2B covalent biologics deal with Enlaza - FirstWord Pharma

Vertex locks on to $2B covalent biologics deal with Enlaza FirstWord Pharma

Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals - Pharmaceutical Executive

Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals Pharmaceutical Executive

Vertex forges $2B-plus alliance with Enlaza to create new autoimmune drugs, improve conditioning methods - Fierce Biotech

Vertex forges $2B-plus alliance with Enlaza to create new autoimmune drugs, improve conditioning methods Fierce Biotech

Vertex teams with Enlaza to expand gene therapy options - The Pharma Letter

Vertex teams with Enlaza to expand gene therapy options The Pharma Letter

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases - Business Wire

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases Business Wire

Vertex enlists Enlaza for gene therapy conditioning and autoimmune disease pact - Endpoints News

Vertex enlists Enlaza for gene therapy conditioning and autoimmune disease pact Endpoints News

Enlaza takes the helm in a $2B+ Vertex deal - BioWorld MedTech

Enlaza takes the helm in a $2B+ Vertex deal BioWorld MedTech

10 Start-Ups to Watch 2024: Enlaza Therapeutics marries covalent and biologic drugs - Chemical & Engineering News

10 Start-Ups to Watch 2024: Enlaza Therapeutics marries covalent and biologic drugs Chemical & Engineering News

Enlaza Raises $100M in Series A Financing Led by JP Morgan’s Life Sciences Group - BioSpace

Enlaza Raises $100M in Series A Financing Led by JP Morgan’s Life Sciences Group BioSpace

Enlaza Nets $100M to Advance Covalent Biologics Platform - Inside Precision Medicine

Enlaza Nets $100M to Advance Covalent Biologics Platform Inside Precision Medicine

Enlaza gets JP Morgan, Regeneron backing for covalent biologics - Yahoo Finance

Enlaza gets JP Morgan, Regeneron backing for covalent biologics Yahoo Finance

Enlaza Therapeutics secures $100m in Series A funding - Pharmaceutical Technology

Enlaza Therapeutics secures $100m in Series A funding Pharmaceutical Technology

White Space for Drug Discovery: Enlaza Therapeutics Grabs $61 Million to Industrialize Covalent Biologics: - Mary Ann Liebert, Inc.

White Space for Drug Discovery: Enlaza Therapeutics Grabs $61 Million to Industrialize Covalent Biologics: Mary Ann Liebert, Inc.

Wilson Sonsini Advises Enlaza Therapeutics on IP Matters Related to $100 Million Series A - Wilson Sonsini

Wilson Sonsini Advises Enlaza Therapeutics on IP Matters Related to $100 Million Series A Wilson Sonsini

Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital - Business Wire

Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital Business Wire

Newly launched Enlaza aims to bring covalency to biologics - Chemical & Engineering News

Newly launched Enlaza aims to bring covalency to biologics Chemical & Engineering News

Enlaza Therapeutics Launches with $61 Million Financing to Advance the First Covalent Biologic Therapeutic Platform - Business Wire

Enlaza Therapeutics Launches with $61 Million Financing to Advance the First Covalent Biologic Therapeutic Platform Business Wire

Companies like Enlaza Geb

Top Enlaza Geb Employees

Andrea Laiton Linares

Coordinadora Predial En Grupo Energía…

Colombia, Colombia

View
CARLOS GRISALES

Gestor De Proyectos De Valor Compartido…

Bogota, D.c., Capital District, Colombia, Colombia

View

1
hotmail.com
Juan Pablo Rizo Molina

n/a

N/a

View
Fredy Zuleta Davila

Gerente General Enlaza - Grupo Energía…

Bogota, D.c., Capital District, Colombia, Colombia

View

1
hotmail.com

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Enlaza Geb company information, Employees & Contact Information

Explore related pages

Company Details

Enlaza Geb Questions

What is Enlaza Geb's official website?

What is Enlaza Geb's LinkedIn profile?

How many employees are working in Enlaza Geb right now?

What is Enlaza Geb's industry?

What are Enlaza Geb's top competitors?

What are Enlaza Geb's categories?

When was Enlaza Geb founded?

News

Editor’s pick: Enlaza Therapeutics - Nature

Firm Advises Enlaza on IP Matters Related to Multi-Target Drug Discovery Collaboration with Vertex Pharmaceuticals - Wilson Sonsini

Vertex locks on to $2B covalent biologics deal with Enlaza - FirstWord Pharma

Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals - Pharmaceutical Executive

Vertex forges $2B-plus alliance with Enlaza to create new autoimmune drugs, improve conditioning methods - Fierce Biotech

Vertex teams with Enlaza to expand gene therapy options - The Pharma Letter

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases - Business Wire

Vertex enlists Enlaza for gene therapy conditioning and autoimmune disease pact - Endpoints News

Enlaza takes the helm in a $2B+ Vertex deal - BioWorld MedTech

10 Start-Ups to Watch 2024: Enlaza Therapeutics marries covalent and biologic drugs - Chemical & Engineering News

Enlaza Raises $100M in Series A Financing Led by JP Morgan’s Life Sciences Group - BioSpace

Enlaza Nets $100M to Advance Covalent Biologics Platform - Inside Precision Medicine

Enlaza gets JP Morgan, Regeneron backing for covalent biologics - Yahoo Finance

Enlaza Therapeutics secures $100m in Series A funding - Pharmaceutical Technology

White Space for Drug Discovery: Enlaza Therapeutics Grabs $61 Million to Industrialize Covalent Biologics: - Mary Ann Liebert, Inc.

Wilson Sonsini Advises Enlaza Therapeutics on IP Matters Related to $100 Million Series A - Wilson Sonsini

Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital - Business Wire

Newly launched Enlaza aims to bring covalency to biologics - Chemical & Engineering News

Enlaza Therapeutics Launches with $61 Million Financing to Advance the First Covalent Biologic Therapeutic Platform - Business Wire

Companies like Enlaza Geb

Cenit Transporte Y L...

Isa Intercolombia

Grupo Energía De Bogotá

Je Jaimes Ingenieros...

Conectagt

Transportadora De Ga...

Isa Interconexión El...

Celsia Energía

Ecopetrol

Enel Colombia

Top Enlaza Geb Employees

Andrea Laiton Linares

Coordinadora Predial En Grupo Energía…

CARLOS GRISALES

Gestor De Proyectos De Valor Compartido…

Juan Pablo Rizo Molina

n/a

Fredy Zuleta Davila

Gerente General Enlaza - Grupo Energía…

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data